Valuation (81%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 13.94 | 9.17 |
PEG Ratio (TTM) | 3.07 | 6.35 |
P/S Ratio (TTM) | 0.67 | 1.94 |
P/B Ratio (TTM) | 1.53 | 14.12 |
P/FCF Ratio (TTM) | 2.05 | 28.33 |
Price to 5YR AVG Earnings Ratio | 2.69 | 13.62 |
Price to 5YR AVG FCF Ratio | 2.10 | 10.62 |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.41% | -19.44% |
ROE (TTM) | 9.37% | -1.71% |
Net Profit Margin (TTM) | 4.78% | -1.87% |
ROIC 5YR AVG | 29.89% | 13.80% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 4.92% | 185.71% | 91.35% |
Revenue | 2.44% | -0.29% | 1.00% |
Net Income | 5.10% | 198.25% | 98.87% |
Cash Flow | 5.70% | -1.48% | 1.32% |
Health (81%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.68 | 1.80 |
Quick Ratio (TTM) | 4.59 | 1.17 |
D/E Ratio (TTM) | 0.77 | 27.03 |
Interest Coverage (TTM) | 27.39 | 66.88 |
Piotroski F-Score | 6 | 5 |
Altman Z-Score | 2.32 | 2.05 |
LTL to 5YR AVG FCF | 1.06 | 7.34 |
Shares Outstanding Growth 5YR AVG | 1.53% | -0.53% |